(2) A thin acrylic plate is rigidly attached to this tube in such a way that the lumen of the tube opens onto the upper surface of the plate. This plate (8 mm. in diameter and approximately circular in outline) is curved to fit and firmly sutured to the sclera. When covered by a flap of conjunctiva and Tenon's capsule, the plate forms the floor of a blel) wvhich is in free communication with the anter-ior chamber aild cannot shrink to an area less than that of the plate. External diameter I-4 mm. Internal diameter 0o75 mm.
(2) EPISCLERAT, PLATE Length 8-5 mm. Breadth 8-5 mm.
Radius of curvature of under surface I I mm.
Greatest thickness o09 mm. Suture holes placed as in Fig. t .
As experiencc vas gained subsequent implants were modified. The most important modification was the grinding of a flat facet on the anterior two-thirds of the upper surface of the plate. This facet allowed aqueous to drain even when the bleb wall became heavily fibrosed (Figs I and 2, opposite).
Additional modifications were made as follows:
(i) Bevelling the outer end of the translimbal tube to prevent erosion through the limbal conjunctiva.
(2) Adding to the facet a gutter leading back from the translimbal tube to distribute aqueous and prevent thinning of the bleb immediately over the "fistula".
(3) Adding to the upper end of each suture hole a radial groove to allow fine sutures to lie flush with the upper surface of the plate so as not to erode through the bleb.
The currently used implant has all the features shown in Fig. i (4) Some cases received in addition to the above medicaments oral glycerol I 50 ml. four times a day.
Cases in which the visual acuity had fallen to less than 6/6o and the intraocular pressure could not be reduced to 20 mm. Hg were admitted to the trial. All remained in hospital under close observation for a minimum of 3 months after the insertion of the implants.
With the exception of two Hottentots all the patients were African Negroes. For details of age, sex, and diagnosis see Table I . (3) A flap of conjunctiva together with the full thickness of Tenon's capsule was dissected up to the limbus and the superficial corneal lamellae split for 2 mm. In order to obtain sufficient exposure of the limbus it was frequently necessary to extend the original incision through conjunctiva and Tenon's capsule across the insertion of the medial (or lateral) rectus.
(4) A 2 mm. disc of "corneo-sclera" was removed by a trephine and a large peripheral iridectomy performed.
(5) An implant with a translimbal tube of length equal to the thickness of the corneo-scleral disc was selected and placed with its tube in the trephine opening.
Implantfor drainage in glaucoma (6) The implant was thenfirmly sutured to the sclera with 7-0 silk. These sutures were placed so that they occupied the grooves in the plate and the knots were well away from the plate. Each suture was tied tight so as to raise a ridge of sclera next to the plate ( The eyes were padded for 24 hours, after which the patient was allowed up wearing dark glasses. All hypotensive therapy was discontinued from the time of operation and gutt. phenylephrine IO per cent. and Sofradex were given as a routine until the eyes became quiet-i.e. from 3 to 6 months later. Undue post-operative iritis was treated by atropinization and subconjunctival injection of DepotMedrol. Nine eyes were given systemic steroids for 2 to 3 months after operation in addition to the above regime.
Complications (i) Vitreous loss in four eyes in which the intraocular pressure could not be reduced to safe levels preoperatively. (2) Persistent flat anterior chamber occurred in two eyes; one reformed spontaneously, and the other after drainage of suprachoroidal fluid. (3) Early perforation of the bleb occurred in six eyes, through buttonholing of the conjunctival flap at operation. In three of these eyes the implant was removed; in three the bleb was successfully repaired.
(4) Late buttonholing of the bleb occurred in two cases which are discussed below. The "hypertensive" stage of increased intraocular pressure coincided with the formation of a thick-walled hyperaemic bleb and the occurrence of a mild iridocyclitis (Fig. 6) .
After 6 to 8 weeks the intraocular pressure fell, and the bleb became less hyperaemic and iritis less severe (Fig. 7) . (Table II) . (3) The implants inserted in cases of uveitis became blocked by exudate during periods of exacerbation, but as soon as the inflammation was overcome drainage was re-established.
Overall clinical results
The results of 47 operations are given in Table V (opposite) . Implants were successfully inserted in 42 eyes and control of the intraocular pressure was achieved in 39 over an average follow-up period of 5j months. The chief cause of failure was early bleb perforation which required the removal of three implants. Two cases discussed below developed late bleb perforations; one required removal of the implant. Two of the five cases of uveitis were failures. One patient died with absolute glaucoma due to uncontrollable sympathetic ophthalmitis 6 weeks after the insertion of an implant (and is therefore omitted from Tables II to IV) . The other failure is an irregular visitor to the outpatients' department, who is maintaining an intraocular pressure between 20 and 28 mm. Hg on irregular hypotensive medication 7 months after insertion. (Tables II, III , IV, and VI)
In cases of primary glaucoma and buphthalmos no hypotensive medication was given for 3 months after insertion. This was done primarily to produce a large distended bleb, but it also allowed an assessment to be made of the effect of the implant alone in different groups, without having to take into account the effect of hypotensive therapy.
In primary open-angle glaucoma the implant produced a mean intraocular pressure of 23 5 mm. Hg at 3 months. In a similar group treated in an identical manner except for the use of systemic steroids, the mean intraocular pressure at 3 months was 13-8 mm. Hg.
In the case of buphthalmos the mean intraocular pressure at 3 months was I9 7 mm. Hg. (3) In the first case, as a result of massive and prolonged steroid therapy used to control the pre-existing uveitis, the bleb became extremely thin. The case of uveitis had the "buttonhole" repaired and at present shows no tendency to extrude I2 months after insertion. The case of post-traumatic glaucoma had the implant removed as it was thought that the membrane separated it from the interior of the eye.
In the remaining cases there has been no tendency for late bleb thinning or elevation of the plate. The essential factor for long-term retention of the implant seems to be that aqueous should drain freely into the bleb. Free drainage produces a heaped bleb which tends to spread beyond the margins of the plate (Fig. 8) . A flat bleb closely applied to the episcleral plate results if free flow of aqueous through the translimbal tube is interrupted at some stage (Fig. 9). glaucoma. Clinical trial. 
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